Does FILGRASTIM-AAFI Cause Off label use? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Off label use have been filed in association with FILGRASTIM-AAFI. This represents 14.4% of all adverse event reports for FILGRASTIM-AAFI.
63
Reports of Off label use with FILGRASTIM-AAFI
14.4%
of all FILGRASTIM-AAFI reports
9
Deaths
4
Hospitalizations
How Dangerous Is Off label use From FILGRASTIM-AAFI?
Of the 63 reports, 9 (14.3%) resulted in death, 4 (6.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM-AAFI. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM-AAFI Cause?
Death (63)
White blood cell count decreased (28)
Hospitalisation (17)
Bone pain (15)
Malaise (15)
Needle issue (15)
Pyrexia (15)
Pain (14)
Device leakage (11)
Drug dose omission by device (11)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which FILGRASTIM-AAFI Alternatives Have Lower Off label use Risk?
FILGRASTIM-AAFI vs FILGRASTIM-SNDZ
FILGRASTIM-AAFI vs FINASTERIDE
FILGRASTIM-AAFI vs FINASTERIDE\TAMSULOSIN
FILGRASTIM-AAFI vs FINERENONE
FILGRASTIM-AAFI vs FINGOLIMOD